Navigation Links
Researcher working on destruction of chemical weapons
Date:9/24/2008

COLLEGE STATION, Sept. 24, 2008 America's war on terror includes fighting the dark side of deadly chemical agents, and Texas A&M University chemist Dr. Frank Raushel is helping with the fight by developing an enzyme that might neutralize one such chemical agent, the organophosphates.

Synthetic organophosphates started their journey as insecticides in the 1930s but soon made their way into the dangerous alleys of chemical warfare during World War II. Raushel, who has been working on detoxification of organophosphates for nearly 10 years, says that the toxic properties of the organophosphate nerve agents are a serious threat to the health and well being of civilized societies.

Although outlawed by several international treaties, some countries have used chemical agents during times of war. In 1988, the Iraqi Kurdish village of Halabja was exposed to multiple chemical agents, killing about 5,000 of the town's 50,000 residents. After the incident, traces of mustard gas and the organophosphates sarin, tabun and VX were discovered.

Raushel, the Davidson Professor of Science at Texas A&M, has been awarded a four-year grant of $1.2 million by the National Institutes of Health to carry out his work on organophosphates.

Organophosphates are neurotoxins they attack the nervous system by blocking the function of the enzyme acetylcholine esterase, which carries nerve signals. When organs such as the lungs do not receive appropriate nerve signals, control is lost over respiratory muscles, and it usually results in death by asphyxiation. Today, some classes of organophosphates are used as insecticides while others have been categorized as chemical weapons.

Researchers have discovered a bacterial enzyme, phosphotriesterase, which can recognize and destroy the toxicity of a broad spectrum of organophosphate nerve agents. What Raushel aims to do is design and characterize bacterial phosphotriesterases that are better at detecting, destroying and detoxifying those organophosphates that pose the most serious threats to human health.


'/>"/>

Contact: Dr. Frank Raushel
raushel@mail.chem.tamu.edu
979-845-3373
Texas A&M University
Source:Eurekalert

Related biology news :

1. Researchers note differences between people and animals on calorie restriction
2. Researchers find an essential gene for forming ears of corn
3. Researchers find animal with ability to survive climate change
4. NC State researchers get to root of parasite genome
5. Wistar Institute researcher receives New Innovator award from NIH
6. UC Davis researchers discover new drug target for inflammatory disease
7. Pittsburgh researchers identify source of multipotent stem cells with broad regenerative potential
8. U of M researchers identify gene linked to common ailment in labrador retrievers
9. Friendly bacteria protect against type 1 diabetes, Yale researchers find
10. Using novel tool, UD researchers dig through cell trash and find treasure
11. More than skin deep: Theres no such thing as a safe suntan, researchers warn
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... 2017  For the thousands of attendees at this year,s International Consumer ... health and biometric measurement devices and services, will be featuring its new ... in A&D Medical,s special CES Exhibit Suite , the new upper ... the company,s WellnessConnected product platform.  ... ...
(Date:12/22/2016)... SuperCom (NASDAQ:   SPCB ... Safety, HealthCare, and Finance sectors announced today that Leaders in Community ... and deploy a community-based supportive services program to reduce recidivism in ... expanding its presence in the state. ... This new program, which is expected to commence ...
(Date:12/16/2016)...   IdentyTechSolutions America LLC , a leading ... and a cutting-edge manufacturer of software and hardware ... seamless, integrated solutions that comprise IDT biometric readers ... provide IdentyTech,s customers with combined physical identification and ... and theft. "We are proud to ...
Breaking Biology News(10 mins):
(Date:1/17/2017)... ... January 17, 2017 , ... ... Rheumatoid Factor (RF) to its VALIDATE® SP2 calibration verification / linearity test kit. ... human serum base. Each VALIDATE® SP2 kit is prepared using the CLSI recommended ...
(Date:1/17/2017)... 17, 2017  An international team of researchers ... St. Boniface Hospital Albrechtsen Research Centre/University of Manitoba ... unmet health need affecting nearly one in 15 ... Investigation, their results identify small molecule drugs with ... neuronal injury in animal models of metabolic, chemical ...
(Date:1/17/2017)... 2017   Pulmatrix, Inc . (NASDAQ: ... inhaled therapies to address serious pulmonary diseases, today announced ... the lungs of CF patients, PUR1900, has been designated ... U.S. Food & Drug Administration. Under ... the development of novel drugs against important pathogens, Pulmatrix ...
(Date:1/17/2017)... Jan. 17, 2017  Only nine percent of U.S. ... profits, while only 16 percent believe health insurance companies ... Meanwhile, 36 percent of U.S. adults believe health care ... profits, compared to hospitals (23%). "We are ... Wendy Salomon , vice president of reputation management ...
Breaking Biology Technology: